Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAD-HF II: Furosemide and Dopamine in ADHF
NCT01060293Phase 4Terminated
- Sponsor
- University Hospital of Larissa
- Start
- Jul 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of furosemide and dopamine in heart failure (HF), sponsored by University Hospital of Larissa. Started Jul 2009; status: terminated.
02
Drugs
furosemidedopamine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01060293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060293.